SA
STOCK ALARM
STOCK ALARM
SA
Menu
Set Alert
Demo
Go Pro
Log In
Today
Workflows
Lists
Find Stocks
The Market
Charts
Research
Advisor
⌘J
LYEL
(LYEL)
LYEL
Overview
Intelligence
Chart
History
Fundmntls
TTM
Earnings
Growth
Analysts
News
Financials
Insiders
Institl.
DCF
Peers
Trailing Twelve Months (TTM) Metrics
Explore More
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance
Home
Screener
Alerts
Search
More
Lyell Immunopharma, Inc.
(LYEL)
$17.30
▲
0.08 (0.46%)
Chart
Share
Post on X
LYEL
Lyell Immunopharma, Inc.
(LYEL)
NASDAQ
$17.30
▲
0.08 (0.46%)
Chart Studio
Share
LYEL
Per Share (TTM)
Revenue/Share
$0.00
Net Income/Share
$-11.26
Operating CF/Share
$-6.12
Free CF/Share
$-6.14
Cash/Share
$11.61
Book Value/Share
$12.51
Tangible Book/Share
$12.51
Equity/Share
$12.51
Interest Debt/Share
$1.81
CapEx/Share
$0.03
Dividend/Share
$0.00
Valuation
Market Cap
$399.48M
Enterprise Value
$348.20M
P/E Ratio
-1.52
P/S Ratio
12,886.44
P/OCF Ratio
-2.80
P/FCF Ratio
-2.97
P/B Ratio
1.37
P/TB Ratio
1.37
EV/Sales
11,232.15
EV/EBITDA
-1.92
Graham Valuation
Graham Number
--
Graham Net-Net
$8.09
Profitability
Earnings Yield
-65.79%
FCF Yield
-33.65%
ROE
-85.71%
ROIC
-61.17%
Return on Tangible Assets
-70.28%
Dividend
Dividend Yield
0.00%
Payout Ratio
0.00%
Capital Allocation
CapEx/OCF
-0.47%
CapEx/Revenue
2009.68%
CapEx/Depreciation
0.06
SBC/Revenue
115500.00%
SG&A/Revenue
131109.68%
R&D/Revenue
489780.65%
Liquidity & Solvency
Debt/Equity
0.14
Debt/Assets
0.11
Debt/Market Cap
0.10
Net Debt/EBITDA
0.28
Current Ratio
7.23
Interest Coverage
0.00x
Income Quality
0.54
Efficiency
Days Sales Outstanding
0 days
Days Payables Outstanding
856 days
Days Inventory
0 days
Receivables Turnover
0.00x
Payables Turnover
0.43x
Inventory Turnover
0.00x
Capital Structure
Tangible Assets
$273.67M
Working Capital
$230.36M
Invested Capital
$280.90M
Intangibles/Assets
0.00%